FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468961921> ?p ?o ?g. }

• W2468961921 endingPage "1509" @default.
• W2468961921 startingPage "1503" @default.
• W2468961921 abstract "Reduced-intensity conditioning (RIC) hematopoietic SCT (HSCT) is a potentially curative therapeutic option for patients with advanced follicular lymphoma (FL), but disease relapse remains the most common cause of failure. Radioimmunoconjugates administered before RIC allo-HSCT may enhance cytoreduction and allow more time for GVL effect to develop without the associated toxicity of a myeloablative HSCT. We performed a retrospective study to describe the outcomes of patients with relapsed, refractory or transformed FL who received yttrium-90 ((90)Y)-ibritumomab tiuxetan followed by fludarabine and low-dose BU RIC allogeneic HSCT at the Dana-Farber Cancer Institute between 2006 and 2009, inclusively. Twelve patients were identified with a median age of 55 (40-66) years and a median number of lines of therapy of 5 (2-10). Two patients (17%) had transformed to a more aggressive histology and five (42%) had chemorefractory FL. Cumulative incidences of grade II-IV acute GVHD at 100 days were 17% (±11%) and chronic GVHD at 12 months were 63% (±19%). Two-year non-relapse mortality was 18% (±12%). Two-year OS and PFS were 83% (±11%) and 74% (±13%), respectively. This treatment is associated with favorable outcomes including acceptable rates of GVHD and relapse in advanced FL patients, and warrants prospective studies." @default.
• W2468961921 created "2016-07-22" @default.
• W2468961921 creator A5002930435 @default.
• W2468961921 creator A5029278364 @default.
• W2468961921 creator A5029390145 @default.
• W2468961921 creator A5031812464 @default.
• W2468961921 creator A5037942629 @default.
• W2468961921 creator A5054037976 @default.
• W2468961921 creator A5068050082 @default.
• W2468961921 creator A5074589634 @default.
• W2468961921 creator A5074955261 @default.
• W2468961921 creator A5077671733 @default.
• W2468961921 creator A5083104525 @default.
• W2468961921 creator A5085801543 @default.
• W2468961921 creator A5086707347 @default.
• W2468961921 date "2011-01-24" @default.
• W2468961921 modified "2023-10-09" @default.
• W2468961921 title "90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma" @default.
• W2468961921 cites W1969261714 @default.
• W2468961921 cites W1978659582 @default.
• W2468961921 cites W1982408296 @default.
• W2468961921 cites W1989425120 @default.
• W2468961921 cites W1990883298 @default.
• W2468961921 cites W2001851267 @default.
• W2468961921 cites W2012972134 @default.
• W2468961921 cites W2019131761 @default.
• W2468961921 cites W2032542882 @default.
• W2468961921 cites W2048483756 @default.
• W2468961921 cites W2052911603 @default.
• W2468961921 cites W2054483729 @default.
• W2468961921 cites W2058887761 @default.
• W2468961921 cites W2059576715 @default.
• W2468961921 cites W2077147663 @default.
• W2468961921 cites W2079507383 @default.
• W2468961921 cites W2092966704 @default.
• W2468961921 cites W2103929387 @default.
• W2468961921 cites W2107466475 @default.
• W2468961921 cites W2107990794 @default.
• W2468961921 cites W2111591374 @default.
• W2468961921 cites W2126539571 @default.
• W2468961921 cites W2132443196 @default.
• W2468961921 cites W2145745667 @default.
• W2468961921 cites W2150297639 @default.
• W2468961921 cites W2154928424 @default.
• W2468961921 cites W2155616447 @default.
• W2468961921 cites W2162489923 @default.
• W2468961921 doi "https://doi.org/10.1038/bmt.2010.339" @default.
• W2468961921 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3139703" @default.
• W2468961921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21258420" @default.
• W2468961921 hasPublicationYear "2011" @default.
• W2468961921 type Work @default.
• W2468961921 sameAs 2468961921 @default.
• W2468961921 citedByCount "16" @default.
• W2468961921 countsByYear W24689619212012 @default.
• W2468961921 countsByYear W24689619212013 @default.
• W2468961921 countsByYear W24689619212014 @default.
• W2468961921 countsByYear W24689619212015 @default.
• W2468961921 countsByYear W24689619212016 @default.
• W2468961921 countsByYear W24689619212017 @default.
• W2468961921 countsByYear W24689619212018 @default.
• W2468961921 countsByYear W24689619212023 @default.
• W2468961921 crossrefType "journal-article" @default.
• W2468961921 hasAuthorship W2468961921A5002930435 @default.
• W2468961921 hasAuthorship W2468961921A5029278364 @default.
• W2468961921 hasAuthorship W2468961921A5029390145 @default.
• W2468961921 hasAuthorship W2468961921A5031812464 @default.
• W2468961921 hasAuthorship W2468961921A5037942629 @default.
• W2468961921 hasAuthorship W2468961921A5054037976 @default.
• W2468961921 hasAuthorship W2468961921A5068050082 @default.
• W2468961921 hasAuthorship W2468961921A5074589634 @default.
• W2468961921 hasAuthorship W2468961921A5074955261 @default.
• W2468961921 hasAuthorship W2468961921A5077671733 @default.
• W2468961921 hasAuthorship W2468961921A5083104525 @default.
• W2468961921 hasAuthorship W2468961921A5085801543 @default.
• W2468961921 hasAuthorship W2468961921A5086707347 @default.
• W2468961921 hasBestOaLocation W24689619211 @default.
• W2468961921 hasConcept C121332964 @default.
• W2468961921 hasConcept C126322002 @default.
• W2468961921 hasConcept C141071460 @default.
• W2468961921 hasConcept C142424586 @default.
• W2468961921 hasConcept C143998085 @default.
• W2468961921 hasConcept C159654299 @default.
• W2468961921 hasConcept C203014093 @default.
• W2468961921 hasConcept C2776146153 @default.
• W2468961921 hasConcept C2776694085 @default.
• W2468961921 hasConcept C2776755627 @default.
• W2468961921 hasConcept C2777058707 @default.
• W2468961921 hasConcept C2777408962 @default.
• W2468961921 hasConcept C2778515704 @default.
• W2468961921 hasConcept C2779263901 @default.
• W2468961921 hasConcept C2779338263 @default.
• W2468961921 hasConcept C2780775027 @default.
• W2468961921 hasConcept C2911091166 @default.
• W2468961921 hasConcept C542903549 @default.
• W2468961921 hasConcept C71924100 @default.
• W2468961921 hasConcept C87355193 @default.
• W2468961921 hasConcept C90924648 @default.
• W2468961921 hasConceptScore W2468961921C121332964 @default.

• next